The weight-loss drug Wegovy slashes the risk of heart disease even before people shed many pounds, data suggests.The drug, which contains the active ingredient semaglutide, works by reducing food cravings and is also available for people with a high BMI.

New research has shown that Ozempic can cause taste changes in people taking it, even going so far as to make some hate the taste of meat.

Fact checked by Jennifer Klump People who use Wegovy for weight management may be at higher risk for hair loss, according to a preprint study. Researchers found that people prescribed semaglutide, the active ingredient in Wegovy,

One weight loss injection has been branded more effective than another, after scientists carry out the first ever head-to-head trial of Mounjaro and Wegovy.

A new study found users of one drug lost almost 50 percent more weight that users of Wegovy. People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s Wegovy in the first head-to-head study of the blockbuster medications.

Wegovy and Ozempic are both semaglutide weight loss medications, but they’re prescribed differently based on who qualifies. Compare side effects here.

Wegovy, a highly effective medication used to treat obesity, shows promise in treating a serious form of liver disease in a new clinical trial. The medication resolved liver inflammation in nearly two-thirds of participants in a major clinical trial,

Novo Nordisk will present data at the European Congress of Obesity (ECO) from a secondary, post hoc analysis of the SELECT trial that showed within the first three months of treatment, reductions in the risk of MACE in adults with obesity and established cardiovascular disease (CVD) were seen.